LFE life therapeutics limited

life therapeutics to supply anti anthrax plasma

  1. fluffynymph
    53,839 Posts.
    lightbulb Created with Sketch. 33
    clock Created with Sketch.
    06/09/06
    12:11
    Post #: 1778100
    Sydney - Wednesday - September 6: (RWE Aust Business News) - Life
    Therapeutics (ASX:LFE) will supply Cangene Corp with anti-anthrax plasma
    to produce a hyperimmune product for the US Department of Health and
    Human Services.
    This is a $US143m project for Cangene under Project BioShield to
    produce 10,000 doses of anthrax immune globulin for treating inhalational
    anthrax.
    LFE Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now
right-arrow Created with Sketch.
NEWS Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate
right-arrow Created with Sketch.
NEWS Check out the latest ASX news here!
right-arrow Created with Sketch.
NEWS Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings
right-arrow Created with Sketch.
NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
NEWS Patronus receives mining approval for Fountain Head
right-arrow Created with Sketch.
watchlist Created with Sketch. Add LFE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.